Can patients with mild non-neoplastic lesions diagnosed at baseline screening be safely exempt from surveillance: evidence from multicenter community-based cohorts-Reference-Cited by-同舟云学术

Can patients with mild non-neoplastic lesions diagnosed at baseline screening be safely exempt from surveillance: evidence from multicenter community-based cohorts

Published:2024-09-06 Issue: Volume: Page:
ISSN:1674-7305
Container-title:Science China Life Sciences
language:en
Short-container-title:Sci. China Life Sci.

Author:

He Siyi,Zhang Zhiyi,Song Guohui,Wang Zhenhai,Dai Chunyun,Yan Shipeng,Jiang Kun,Song Bingbing,Li He,Cao Maomao,Sun Dianqin,Yang Fan,Yan Xinxin,Zhang Shaoli,Teng Yi,Li Qianru,Xia Changfa,Chen Wanqing

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11427-023-2558-x.pdf

Reference47 articles.

1. Akbari, M., Kardeh, B., Tabrizi, R., Ahmadizar, F., and Lankarani, K.B. (2019). Incidence rate of gastric cancer adenocarcinoma in patients with gastric dysplasia: a systematic review and meta-analysis. J Clin Gastroenterol 53, 703–710.

2. Arnold, M., Abnet, C.C., Neale, R.E., Vignat, J., Giovannucci, E.L., McGlynn, K.A., and Bray, F. (2020). Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 159, 335–349.e15.

3. Bae, J.M. (2020). Body mass index and risk of gastric cancer in Asian adults: a metaepidemiological meta-analysis of population-based cohort studies. Cancer Res Treat 52, 369–373.

4. Banks, M., Graham, D., Jansen, M., Gotoda, T., Coda, S., di Pietro, M., Uedo, N., Bhandari, P., Pritchard, D.M., Kuipers, E.J., et al. (2019). British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 68, 1545–1575.

5. Cao, M., Li, H., Sun, D., He, S., Yu, Y., Li, J., Chen, H., Shi, J., Ren, J., Li, N., et al. (2021). Cancer screening in China: the current status, challenges, and suggestions. Cancer Lett 506, 120–127.